Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC by Vansteenkiste, Johan F., Naidoo, Jarushka, Faivre-Finn, Corinne, Özgüroğlu, Mustafa, Villegas, Augusto, Daniel, Davey, Murakami, Shuji, Hui, Rina, Lee, Ki Hyeong, Cho, Byoung Chul, Kubota, Kaoru, Broadhurst, Helen, Wadsworth, Catherine, Newton, Michael, Thiyagarajah, Piruntha, Antonia, Scott J.

Get full text

Symptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer by Vansteenkiste, Johan F., MD, PhD, Naidoo, Jarushka, MB, BCH, MHS, Faivre–Finn, Corinne, MD, PhD, Özgüroğlu, Mustafa, MD, Villegas, Augusto, MD, Daniel, Davey, MD, Murakami, Shuji, MD, Hui, Rina, MBBS, PhD, Lee, Ki Hyeong, MD, Cho, Byoung Chul, MD, PhD, Kubota, Kaoru, MD, PhD, Broadhurst, Helen, MSc, Wadsworth, Catherine, BVSc, Newton, Michael, PharmD, Thiyagarajah, Piruntha, MD, Antonia, Scott J., MD

Get full text

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR by Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K, Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A Kate, Schecter, Jordan M, Mateos, Maria-Victoria

Get full text